Topical antifungal agents used for dermatophytes

2. Dei Cas E, Vernes A. Parasitic adaptation of pathogenic fungi to mammalian hosts. Crit Rev Microbiol. 1986;13:173218.

3. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs. 1998;55:64574.

4. Roberts SO. Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol. 1969;81:31526.

5. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. J Am Acad Dermatol. 1996;34[2 pt 1]:2826.

6. Stern RS. The epidemiology of cutaneous disease. In: Freedberg IM, Fitzpatrick TB, eds. Fitz-patrick's Dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999:712.

7. Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol. 1994;31[3 pt 2]:S215.

8. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:53942.

9. Dahl MV. Suppression of immunity and inflammation by products produced by dermatophytes. J Am Acad Dermatol. 1993;28[5 pt 1]:S1923.

10. La Touche CJ. Scrotal dermatophytosis. An insufficiently documented aspect of tinea cruris. Br J Dermatol. 1967;79:33944.

11. McAleer R. Fungal infection as a cause of skin disease in Western Australia. Australas J Dermatol. 1980;21:2546.

12. Philpot CM. Some aspects of the epidemiology of tinea. Mycopathologia. 1977;62:313.

13. Habif TP. Superficial fungal infections. In: Clinical dermatology: a color guide to diagnosis and therapy. Habif TP, ed. 3d ed. St. Louis: Mosby, 1996:362408.

14. Rasmussen JE. Cutaneous fungus infections in children. Pediatr Rev. 1992;13:1526.

15. Bergus GR, Johnson JS. Superficial tinea infections. Am Fam Physician. 1993;48:25968.

16. Kenyon J, ed. Dermatology Practice Administration: CLIA 88. American Academy of Dermatology. Chambourg, Ill.: Knapp, 1993.

17. Fitzpatrick TB, Johnson RA, Wolff K, Polano MK, Suurmond D. Cutaneous fungal infections. In: Color atlas and synopsis of clinical dermatology: common and serious diseases. Fitzpatrick TB, et al., eds. 3d ed. New York: McGraw-Hill, 1997:688733.

18. Taplin D, Zaias N, Rebell G, Blank H. Isolation and recognition of dermatophytes on a new medium [DTM]. Arch Dermatol. 1969;99:2039.

19. Head ES, Henry JC, Macdonald EM. The cotton swab technic for the culture of dermatophyte infectionsits efficacy and merit. J Am Acad Dermatol. 1984;11[5 pt 1]:797801.

20. Diehl KB. Topical antifungal agents: an update. Am Fam Physician. 1996;54:168792.

21. Barrett-Bee KJ, Lane AC, Turner RW. The mode of antifungal action of tolnaftate. J Med Vet Mycol. 1986;24:15560.

22. Weinstein MJ, Oden EM, Moss E. Antifungal properties of tolnaftate in vitro and in vivo. Antimicrob Agents Chemother. 1964;3:595601.

23. Hermann HW. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent. Arch Dermatol. 1972;106:83942.

24. Rudolph RL. Allergic contact dermatitis caused by haloprogin. Arch Dermatol. 1975;111:14878.

25. Aly R, Maibach HI, Bagatell FK, Dittmar W, Hanel H, Falanga V, et al. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther. 1989;11:290303.

26. Penlac package insert. Dermik Laboratories, 2000. Retrieved May 2001, from: www.dermik.com/prod/penlac/pi.html.

27. Nussbaumer P, Dorfstatter G, Grassberger MA, Leitner I, Meingassner JG, Thirring K, et al. Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment. J Med Chem. 1993;36:211520.

28. Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol. 1997;36[2 pt 1]:S914.

29. Lester M. Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. Cutis. 1995;55:1813.

30. Polak A. Antifungal activity of four antifungal drugs in the cutaneous retention time test. Sabouraudia. 1984;22:5013.

31. Hill S, Thomas R, Smith SG, Finlay AY. An investigation of the pharmacokinetics of topical terbinafine [Lamisil] 1% cream. Br J Dermatol. 1992;127:396400.

32. Meinicke K, Striegel C, Weidinger G. Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration. Mykosen. 1984;27:60814.

33. Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T, et al. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole. Australas J Dermatol. 1999;40:197200.

34. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126[suppl 39]:27.

35. Bonifaz A, Saul A. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. Eur J Dermatol. 2000;10:1079.

36. Leenutaphong V, Niumpradit N, Tangwiwat S, Sri-taveesuwan R, Muanprasat C. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis. J Med Assoc Thai. 1999;82:100610.

37. Evans EG, Seaman RA, James IG. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br J Dermatol. 1994:130:837.

38. Nada M, Hanafi S, al-Omari H, Mokhtar M, el-Shamy S, Muhlbacher J. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections. Int J Dermatol. 1994;33:5702.

39. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, et al. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. J Am Acad Dermatol. 1992;26:1257.

40. Wortzel MH. A double-blind study comparing the superiority of a combination antifungal [clotrimazole]/steroidal [betamethasone dipropionate] product. Cutis. 1982;30:25861.

41. Katz HI, Bard J, Cole GW, Fischer S, McCormick GE, Medansky RS, et al. SCH 370 [clotrimazole-betamethasone dipropionate] cream in patients with tinea cruris or tinea corporis. Cutis. 1984;34:1838.

42. Smith ES, Fleischer AB Jr, Feldman SR. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 19901994. J Am Acad Dermatol. 1998;39:437.

43. Lotrisone. Package insert. Schering Corporation, Kenilworth, N.J.: 1994.

Video liên quan